Cas:1221792-08-0 6-methylsulfonylpyridine-3-carbaldehyde manufacturer & supplier

We serve Chemical Name:6-methylsulfonylpyridine-3-carbaldehyde CAS:1221792-08-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

6-methylsulfonylpyridine-3-carbaldehyde

Chemical Name:6-methylsulfonylpyridine-3-carbaldehyde
CAS.NO:1221792-08-0
Synonyms:6-(methylsulfonyl)nicotinaldehyde;methylsulfonylnicotinaldehyde
Molecular Formula:C7H7NO3S
Molecular Weight:185.20000
HS Code:2933399090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:72.48000
Exact Mass:185.01500
LogP:1.37840

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 6-(methylsulfonyl)nicotinaldehyde chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,methylsulfonylnicotinaldehyde physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,6-(methylsulfonyl)nicotinaldehyde Use and application,6-(methylsulfonyl)nicotinaldehyde technical grade,usp/ep/jp grade.


Related News: The European Commission (EC) has approved MSD and Bayer’s Verquvo for the treatment of symptomatic chronic heart failure in patients with reduced ejection fraction. 2-methyl-5-methylsulfanyl-pent-1-en-3-yne manufacturers The European Commission (EC) has approved MSD and Bayer’s Verquvo for the treatment of symptomatic chronic heart failure in patients with reduced ejection fraction. 4-(4,8-dimethyl-quinolin-2-ylamino)-1,5-dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one suppliers The European Commission (EC) has approved MSD and Bayer’s Verquvo for the treatment of symptomatic chronic heart failure in patients with reduced ejection fraction. 2ref-Brom-3-cis-ethoxyacrylsaeure vendor & factory But when it came to deciding on whether Americans with compromised immune systems should get an extra dose of any COVID-19 vaccine, the CDC said it would need to wait for the FDA to give its regulatory thumbs up first. That could come either through amending its emergency use nods or awarding full approvals.,Stevanato’s been out of start-up mode for a while: The firm doubled its net profit to $94 million in 2020 on $779 million in revenues, which were up 23% from 2019. That strong growth in sales helped place Sergio Stevanato, 79, Giovanni’s son and the company’s chairman emeritus, on Forbes’ World’s Billionaires list for the first time in 2021, with a net worth of $1.9 billion.